A6| Saturday/Sunday, March 14 - 15, 2020 **** THE WALL STREET JOURNAL.
three to four days to find out if
a patient had coronavirus, phy-
sicians said. Test results typi-
cally take 8 hours, a university
spokeswoman said.
In the past week, testing has
increased after the CDC relaxed
its criteria, allowing any person
with symptoms who is high
risk, who recently traveled to a
hot spot or who came into con-
tact with an infected person to
get tested.
But the volume of patients
with symptoms and the need
for enough personal protective
equipment, called PPE’s, to
treat them remained a concern.
Dr. Tu thought the medical
clinics he oversaw at Everett
were adequately stocked with
30,000 of the surgical masks.
But the rate of use jumped to
3,000 a day from the 1,000 that
is typical in flu season.
On the verge of running out
last week, he had to reach out to
the Strategic National Stockpile,
the nation’s emergency reserve
of critical drugs and medical
EVAN VUCCI/ASSOCIATED PRESS
Treasury SecretaryStevenMnuchin spoke with reporters Friday at the White House about the economic impact of the coronavirus.
The Trump administration
said it would increase access to
coronavirus testing even as a
fresh potential problem looms:
The U.S. is facing a dwindling
supply of the products and
chemicals needed to run the
tests.
Top administration officials
have told lawmakers they are
aware the supplies are short
and are researching the issue.
Some congressional and state
lawmakers, as well as public-
health leaders, are pressing the
White House to do more, say-
ing they are already having
problems getting certain mate-
rials and a deepening shortage
could hobble testing nation-
wide, even as millions of tests
are deployed.
The administration took
steps Friday to try to advance
testing with a screening web-
site where people can fill out a
questionnaire, check symptoms
and risk factors, and learn
where drive-through options
are for getting tested.
The goal, officials said, is to
have labs use automated ma-
chines enabling them to pro-
vide results in 24 to 36 hours.
“I understand that a lot of
this behind-the-scenes action
over the last couple of weeks
was invisible to the press and
the American people,” said Am-
bassador Deborah Birx, special
representative for global health
diplomacy, at a news briefing at
the White House.
the new coronavirus.
At times, communication be-
came so siloed that the mayor
of Kirkland, at the outbreak’s
epicenter, resorted to calling
every elected official she
could—including her husband,
a state legislator—to get fed-
eral officials to move faster.
“We need to have something
happen. You need to understand
what is happening. People are
dying,” Mayor Penny Sweet re-
called telling Washington Gov.
Jay Inslee’s chief of staff.
Tim Dellit, UW Medicine’s
chief medical officer, and other
Seattle hospital leaders on
March 2 urged state officials to
persuade the Centers for Dis-
ease Control and Prevention to
adopt the World Health Organi-
zation’s guidelines for medical
staff’s protective gear, which
allow for less-specialized masks
to fight coronavirus than those
recommended by the CDC.
“We cannot manage the in-
creasing numbers of patients
presenting with possible
Covid-19 and creating more risk
for our health care workers
given the complexities of the
current CDC recommenda-
tions,” Dr. Dellit’s letter said.
At first, John Lynch, head of
infection prevention and con-
trol at Seattle’s Harborview
Medical Center, had anticipated
clusters of coronavirus cases
would pop up and spread—sim-
ilar to the flu.
When state officials an-
nounced on Feb. 29 the first re-
ported coronavirus death in the
U.S. occurred at Evergreen-
Health, and that sick patients
from there had been at Life Care,
it jogged the memory of a nurse
at Dr. Lynch’s hospital. The nurse
recalled a patient had died at
Harborview on Feb. 26, after be-
ing transferred from Life Care.
The county medical exam-
iner’s office subsequently con-
firmed the Harborview patient
tested positive for coronavirus,
meaning the first death from
Covid-19 happened earlier than
previously known.
“You’re going to need to call
everyone on staff,” Dr. Lynch
told a hospital fellow assigned
to his team.
On those first few days, the
CDC’s testing protocols for the
illness were both too narrow,
focused on travel to known
global hot spots, and took too
long to get results, physicians
said. While waiting, hospital
leaders had to isolate patients
who mightn’t have been in-
fected and burn through dwin-
dling protective equipment.
“It was incredibly frustrat-
ing,” Dr. Lynch said.
The University of Washing-
ton lab got so swamped that
doctors were having to wait
equipment, as well as to Ever-
ett’s parent, UnitedHealth Group,
to arrange emergency shipments.
Realizing he was also about
to run out of the special N
respirators used by staff to
treat coronavirus, Dr. Tu began
digging through Everett’s stor-
age facility until he found alter-
native respirators. But they
didn’t fit snugly enough so staff
jury-rigged the remaining N
devices to last longer.
The Trump administration
has requested more supplies be
added to the national stockpile.
Washington state has asked
federal officials for respirators
and masks twice.
As it became clear that the vi-
rus was tearing through Life
Care, Kirkland officials struggled
to get clear guidance from county
and federal health officials.
The mayor and her staff be-
gan asking for a specialized
federal disaster medical-assis-
tance team to take over the fa-
cility. It took several days of
frustrating back and forth, and
Ms. Sweet calling elected offi-
cials, to find out when the team
would arrive, she said.
By the middle of this past
week, coronavirus had spread
to 10 other Seattle-area elder-
care facilities, which reported
at least three more deaths.
—Melanie Evans
contributed to this article.
Washington were among the
first in the nation to face the cri-
sis, as well as the lumbering re-
sponse from federal health offi-
cials and equipment shortages
that they say have slowed their
ability to contain the virus.
Despite the disaster training
that the region’s medical care
systems have undergone, the
coronavirus crisis exposed crit-
ical gaps. Those on the front
lines in the Seattle area have
had to plead for more re-
sources, demand changes to re-
strictive infectious-disease pro-
tocols, and create their own
rules on the fly.
“There’s a great military
term: ‘No battle plan survives
first contact with the enemy,’ ”
said Jeff Tomlin, a former Ma-
rine Corps pilot who is now
chief executive of Evergreen-
Health, near the Life Care Cen-
ter of Kirkland, a long-term-
care facility where nearly two
dozen deaths are linked to
Covid-19, the illness caused by
ContinuedfromPageOne
Shortages
Slow Down
Hospitals
THE CORONAVIRUS PANDEMIC
businesses with fewer than 50
employees could win an ex-
emption from paying emer-
gency sick leave if they could
prove hardship.
Mr. Trump also wrote on
Twitter that he had instructed
Mr. Mnuchin and Labor Secre-
tary Eugene Scalia to propose
regulations to ensure the leg-
islation doesn’t hurt small
businesses. He didn’t offer de-
tails on the regulations.
Congress last week passed
an $8.3 billion measure to help
the government develop a vac-
cine and provide money for
states to expand their lab test-
ing capacity and attempt to
limit the damage from the vi-
rus. Efforts to put together a
new package came together
only this week—as the number
of cases in the U.S. exceeded
1,000, stock prices plunged,
and sports and cultural events
were canceled nationwide
The package would provide
free coronavirus testing to any-
one whose doctor says they
need a test and allow for as
much as 14 days of paid sick
leave and as much as three
months of paid family and med-
ical leave. It would also provide
more funding for state Medicaid
programs, although less than
what Democrats had proposed
in their original legislation.
Should it pass the House,
the measure would go to the
Senate. Majority Leader Mitch
McConnell (R., Ky.) has can-
celed next week’s recess to be
available to work on a corona-
virus response.
Republicans were especially
concerned about small busi-
nesses, which they warned
could face disruptions with so
many out-of-work employees,
as well as cash-flow problems
even if they were later reim-
bursed for their costs through
a tax credit. In a last-minute
deal, negotiators agreed that
date that requires companies
with fewer than 500 workers
to pay up to 14 days of emer-
gency sick leave to certain
workers who were exposed to
coronavirus, as well as people
whose family members were
exposed or who faced child-
care problems because of the
coronavirus crisis.
met at the White House Friday
night to go over the final details
of the bill and he eventually
signed off, according to a White
House official. Mr. Mnuchin also
spoke with Mrs. Pelosi during
Mr. Trump’s Friday afternoon
news conference.
Negotiations bogged down
late Friday over a new man-
sury Secretary Steven
Mnuchin, who stayed in close
contact with the House
speaker throughout the week.
The president signaled ear-
lier in the day that he wasn’t
ready to reach an agreement on
the legislation, saying Demo-
crats weren’t giving him enough.
But Mr. Trump and Mr. Mnuchin
WASHINGTON—Demo-
crats and the White House
reached an agreement on leg-
islation that would make coro-
navirus testing free and pro-
vide paid sick leave to many of
those affected by the pan-
demic as it continues to
spread across the country.
President Trump endorsed
the legislation in a Friday night
tweet, ending hours of confu-
sion about whether he would
back the bill amid a last-minute
disagreement about the text.
“I encourage all Republi-
cans and Democrats to come
together and VOTE YES! I will
always put the health and
well-being of American fami-
lies FIRST. Look forward to
signing the final Bill, ASAP!”
Mr. Trump wrote in a series of
tweets shortly before 9 p.m.
House Speaker Nancy Pelosi
was expected to hold a vote on
the bill Friday night. She had
announced a deal earlier Fri-
day in a letter to lawmakers.
“This legislation is about
testing, testing, testing,” Mrs.
Pelosi said. “To stop the
spread of the virus, we have
secured free coronavirus test-
ing for everyone who needs a
test, including the uninsured.”
Mr. Trump’s tweets gave
House Republicans confidence
to back the spending legisla-
tion, knowing that the presi-
dent would sign it and ended
days of intense negotiations
between Mrs. Pelosi and Trea-
But the scarcity of some of
the testing materials and prod-
ucts could undermine President
Trump’s efforts to fend off crit-
icism over the government’s re-
sponse to the virus. About
1,600 people in the U.S. have
tested positive for coronavirus,
businesses have told workers to
stay home and many schools
have closed in an effort to slow
the spread.
Administration officials in-
cluding Vice President Mike
Pence said millions of tests
would be available, and Mr.
Trump said last week that
“anyone who wants a test can
get a test.”
But labs and some states say
that hasn’t been the case. Spe-
cific agents that allow the virus
to be extracted for the tests are
running low, they say, as are
supplies of chemicals for test-
ing.
Labs also said there are con-
cerns about collection supplies
at locations where people are
tested, including swabs, respi-
rators and media to transport
the virus as well as masks and
gloves.
“We’ve shared our concerns
with the administration and the
CDC about possible shortages
of supplies,” a spokeswoman
for the American Clinical Labo-
ratory Association said, refer-
ring to the Centers for Disease
Control and Prevention. “We’re
concerned there could be chal-
lenges as we step up increased
demand and screen more speci-
mens.”
Adriane Casalotti, chief of
government of public affairs at
the National Association of
County and City Health Offi-
cials, said the problems will
worsen if more people develop
symptoms and need testing.
“Even if labs don’t have
shortages now, there are only a
handful of suppliers. It’s going
to be a national problem,” said
Ms. Casalotti, whose organiza-
tion represents the country’s
nearly 3,000 local health de-
partments “When you’re think-
ing of testing thousands of
thousands of thousands of peo-
ple, it puts all these materials
at risk.”
The American Society for
Microbiology, whose member-
ship includes thousands of pub-
lic-health and clinical labora-
tory microbiologists, also
sounded a warning.
“We are deeply concerned
that as the number of tests in-
creases dramatically over the
coming weeks, clinical labs will
be unable to deploy them with-
out these critical components,”
the organization said in a state-
ment.
Private labs that are per-
forming coronavirus tests are
closely watching the supply of
materials needed for testing.
Quest Diagnostics Inc., which
launched coronavirus testing,
said it uses some of the same
chemicals as used in tests from
the CDC.
“We are managing supply
and believe we have adequate
supply at least for the time be-
ing,” said Rachel Carr, a spokes-
woman for the company.
Democrats are raising the
alarm: California Gov. Gavin
Newsom said Thursday that
test kits received from the CDC
didn’t include the ingredients
that are in short supply, and Il-
linois Sens. Dick Durbin and
Tammy Duckworth have pushed
the agency for more informa-
tion.
“This is imperative that the
federal government and labs
across the United States—not
the state of California—get the
benefit of all the ingredients
that are components of the
test,” Mr. Newsom said.
On Thursday, Dr. Anthony
Fauci, director of the National
Institute of Allergy and Infec-
tious Diseases, said in congres-
sional testimony that the na-
tion’s system for disease
testing has failed during the
coronavirus crisis because peo-
ple typically need a doctor’s
permission to be tested.
“The system is not really
geared to what we need right
now,” Dr. Fauci said. “That is a
failing. It is a failing. Let’s ad-
mit it.”
—Denise Roland
and Peter Loftus
contributed to this article.
BYSTEPHANIEARMOUR
ANDTHOMASM.BURTON
Supply of Products, Materials Used for Testing Falls
Specific agents that
allow the virus to be
extracted for the
tests are running low.
Under 10
10–
20–
30–
40–
50–
60–
70–
80+
0.0%
0.
0.
0.
0.
1.
3.
8.
14.
Cardiovascular disease
10.5%
Diabetes
7.
Chronic respiratory disease
6.
Hypertension
6.
Cancer
5.
None
0.
Overalldeathrate:2.3%
Who’s Vulnerable?
Among a large group of early patients in China, the death rate
was highest for people over 60 or with underlying illnesses.
Initial cases in the U.S. and South Korea show similar patterns.
Death rate among patients in China diagnosed with the new
coronavirus through Feb. 11
By age group
Deaths in the U.S. and South Korea, by age group
As of March 11
By underlying condition
Under 10
AGE U.S. deaths* South Korea
10-
20-
30-
40-
50-
60-
70-
80+
*Does not include two deaths where the age was not reported.
Sources: Chinese Center for Disease Control and Prevention (death rates); local health officials
(U.S. deaths); Sang Woo Park, Princeton University (South Korea deaths)
Lindsay Huth/THE WALL STREET JOURNAL
1
1
6
14
21
17
1
none
none
none
none
none
none
none
2
5
9
18
BYNATALIEANDREWS
ANDLINDSAYWISE
Trump, Democrats Reach Deal on Virus Bill
Nurses tested UW Medicine staff Tuesday, at a makeshift site in
a Seattle parking garage.
JOVELLE TAMAYO FOR THE WALL STREET JOURNAL